Connection

Bob Poyer to Radiopharmaceuticals

Back to Details
This is a "connection" page, showing publications Bob Poyer has written about Radiopharmaceuticals.
Bob Poyer
Connection Strength
0.032
Radiopharmaceuticals
  1. Diagnostic performance of whole body dual modality 18F-FDG PET/CT imaging for N- and M-staging of malignant melanoma: experience with 250 consecutive patients. J Clin Oncol. 2006 Mar 01; 24(7):1178-87.
    View in: PubMed
    Score: 0.032
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.